Does NIRSEVIMAB-ALIP Cause Dyspnoea? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Dyspnoea have been filed in association with NIRSEVIMAB-ALIP. This represents 1.7% of all adverse event reports for NIRSEVIMAB-ALIP.
13
Reports of Dyspnoea with NIRSEVIMAB-ALIP
1.7%
of all NIRSEVIMAB-ALIP reports
0
Deaths
9
Hospitalizations
How Dangerous Is Dyspnoea From NIRSEVIMAB-ALIP?
Of the 13 reports, 9 (69.2%) required hospitalization, and 1 (7.7%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRSEVIMAB-ALIP. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does NIRSEVIMAB-ALIP Cause?
Drug ineffective (173)
Respiratory syncytial virus bronchiolitis (135)
Bronchiolitis (83)
Incorrect dose administered (80)
Respiratory syncytial virus infection (76)
Pyrexia (54)
Cough (45)
Respiratory syncytial virus test positive (36)
Extra dose administered (30)
Product storage error (30)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which NIRSEVIMAB-ALIP Alternatives Have Lower Dyspnoea Risk?
NIRSEVIMAB-ALIP vs NITAZOXANIDE
NIRSEVIMAB-ALIP vs NITISINONE
NIRSEVIMAB-ALIP vs NITRAZEPAM
NIRSEVIMAB-ALIP vs NITRENDIPINE
NIRSEVIMAB-ALIP vs NITRIC